✦ LIBER ✦

Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas

✍ Scribed by G. B. Bradac; R. Soffietti; A. Riva; G. Stura; S. Sales; D. Schiffer

Publisher: Springer
Year: 1992
Tongue: English
Weight: 883 KB
Volume: 34
Category: Article
ISSN: 0028-3940
DOI: 10.1007/bf00588438

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous BCNU and AZQ in patients wit

Intravenous BCNU and AZQ in patients with recurrent malignant gliomas

✍ W.K.A. Yung; M.I. Harris; J.M. Bruner; L.G. Feun 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 293 KB

Twenty-four patients with recurrent malignant glioma were treated with intravenous BCNU (80 mg/m2/ day x 3 days) alternating with AZQ (8 mg/mZ/day x 5 days) every 6--8 weeks. Twenty patients received two or more courses of chemotherapy, ten anaplastic astrocytomas (AA), eight glioblastomas (GBM), an

Visual toxicity following intra-arterial

Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas

✍ G. Defer; F. Fauchon; M. Schaison; J. Chiras; P. Brunet 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 630 KB

Complications associated with intra-arte

Complications associated with intra-arterial BCNU administered in combination with vincristine and procarbazine for the treatment of malignant brain tumors

✍ Alfonso M Bremer; Enrique Kleriga; Tai Q Nguyen; Raymond Balsys; H Martin Northu 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 301 KB

We have used intra-arterial (i.a.) 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) either alone or as part of adjuvant chemotherapy in patients with malignant brain tumors over a 3 year period (1979-1982). The i.a. BCNU technique was used 111 times to infuse 134 arteries in 37 patients. These patients,